company background image
AVH logo

AVITA Medical CHIA:AVH Stock Report

Last Price

AU$3.64

Market Cap

AU$488.8m

7D

6.7%

1Y

-10.1%

Updated

12 Nov, 2024

Data

Company Financials +

AVITA Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AVITA Medical
Historical stock prices
Current Share PriceUS$3.64
52 Week HighUS$5.61
52 Week LowUS$2.34
Beta1.54
11 Month Change23.39%
3 Month Change26.39%
1 Year Change-10.12%
33 Year Change-18.20%
5 Year Change-67.79%
Change since IPO51.67%

Recent News & Updates

Recent updates

Shareholder Returns

AVHAU BiotechsAU Market
7D6.7%0.8%1.1%
1Y-10.1%17.8%18.3%

Return vs Industry: AVH underperformed the Australian Biotechs industry which returned 17.8% over the past year.

Return vs Market: AVH underperformed the Australian Market which returned 18.3% over the past year.

Price Volatility

Is AVH's price volatile compared to industry and market?
AVH volatility
AVH Average Weekly Movement6.9%
Biotechs Industry Average Movement10.1%
Market Average Movement8.4%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.5%

Stable Share Price: AVH has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: AVH's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2020207Jim Corbettwww.avitamedical.com

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time.

AVITA Medical, Inc. Fundamentals Summary

How do AVITA Medical's earnings and revenue compare to its market cap?
AVH fundamental statistics
Market capAU$488.77m
Earnings (TTM)-AU$87.59m
Revenue (TTM)AU$91.75m

5.3x

P/S Ratio

-5.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AVH income statement (TTM)
RevenueUS$60.04m
Cost of RevenueUS$8.61m
Gross ProfitUS$51.43m
Other ExpensesUS$108.75m
Earnings-US$57.32m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.19
Gross Margin85.66%
Net Profit Margin-95.47%
Debt/Equity Ratio348.0%

How did AVH perform over the long term?

See historical performance and comparison